AGP Executive Report

US Health Policy & Politics: Former top US infectious-disease adviser Anthony Fauci again invoked the Fifth Amendment during a Senate hearing, refusing to answer questions on COVID-19 origins and pandemic decisions, as Republicans weigh contempt steps. Public Health Research: A study suggests limiting sugar intake before age two may reduce later dementia risk. Childhood Adversity: A Hong Kong cohort study links childhood maltreatment to higher adult risk across 13 disease categories, including mental health multimorbidity. Gut-Brain Therapy: A small trial reports fecal microbiota transplantation improved objective sleep measures in chronic insomnia. China Health & Safety: China’s largest “artificial sun” magnet test marks progress toward future thermonuclear energy, while separate reports highlight ongoing scrutiny of gene-editing oversight after a fatal experimental therapy case. Healthcare Access: AstraZeneca backed down on Australia’s plan to pull a breast cancer/endometriosis drug, committing to indefinite supply for eligible patients. China-Related Health Diplomacy: China’s 50-year medical cooperation with Mozambique continues, with hundreds of clinicians and millions of patients served.

US Policy Shift on Lab-Leak Research: The US announced new limits on “gain-of-function” biological research funding, tightening oversight for high-risk pathogen work tied to Covid-19 origins claims. Food Safety & Packaging: A China-based guide argues “food-grade” labels aren’t enough—buyers should verify resin, temperature limits, seals, and paperwork for food-contact plastic buckets. China’s Health-Adjacent Trade Push: China’s Commerce Ministry says export surpluses don’t automatically mean “overcapacity,” urging objective views and more imports. Primary Care & Hepatitis Focus (China): Coverage highlights China’s push to expand hepatitis B testing and prevention, including combining TCM and Western medicine approaches. Animal Health & Pet Industry: VIV Select China and Pet Fair Asia will launch a joint platform in Shanghai, linking livestock biosecurity and animal health with the global pet market. South China Sea Rescue: After a Vietnamese cargo ship sank near a Chinese outpost, survivors rose to 48 with 14 still missing as rescue operations continue. Parkinson’s Risk & Traffic Noise: A long-term study links higher road-traffic noise exposure to a modest increase in Parkinson’s disease risk. CIIE Participation: Multinationals are lining up for the China International Import Expo, citing China’s market size and innovation ecosystem.

TCM Access Push: China plans to bring higher-quality traditional Chinese medicine services within a 15-minute reach of residents over the next five years, with a new grassroots action plan aimed at boosting county-level capacity and workforce. Hepatitis Care Integration: Hospitals are increasingly combining TCM with Western medicine to treat hepatitis B, reflecting renewed focus as China marks World Hepatitis Day and targets better prevention and care to curb progression to liver cancer. Oral Health & Inflammation: A new study links periodontitis to “central immune remodeling,” showing how gum inflammation can reprogram bone marrow neutrophils and drive systemic inflammation—raising the stakes for early gum disease treatment. Bone Health Breakthrough: Researchers report that blocking the AXL receptor may promote bone formation, offering a potential new, more accessible osteoporosis therapy direction. Disaster Response & Rehab: Premier Li Qiang inspected Tangshan and stressed stronger disaster prevention and emergency response, including improved medical rehabilitation and support for people with disabilities. Aviation Safety: A power bank fire aboard a China Eastern Airlines flight renewed warnings about lithium-ion battery risks and why airlines restrict carrying and storing portable chargers. Medical Tourism/Training: Peking Union Medical College Hospital teams with Macao Union Hospital to complete complex spinal deformity surgeries, marking a capability milestone for high-risk procedures in Macau. Drug Safety Alert: U.S. customs seized bogus “unapproved medications” shipped from China, including erectile dysfunction and weight-loss drugs, highlighting ongoing cross-border counterfeit risks.

Animal-testing alternatives: China’s National Medical Products Administration (NMPA) is seeking public input on a new plan to promote “new approach methodologies” that could reduce or replace traditional animal testing in drug development, including AI-based simulations and lab-grown organoid/organ-on-chip methods. Prenatal care innovation: Gene Solutions highlighted real-world evidence and AI-enabled pregnancy-risk assessment at an international prenatal diagnosis conference, pushing for more comprehensive, minimally invasive women’s health screening. Healthcare procurement pressure: Philips said delayed U.S. orders and tougher China conditions—linked to centralized procurement rules for public medical institutions—hit its second-quarter results, even as it lifted its full-year margin outlook. Drug market watch: AstraZeneca reported China revenue fell in the first half, citing slower growth in key products and centralized procurement pressures that cost it market share in public hospitals. Public health systems: China is targeting 2030 for expanded respiratory disease surveillance covering more than 15 pathogens, signaling a stronger early-warning push. Safety and ethics in medicine: Japan police rearrested a suspected organ-transplant broker tied to illegal kidney transplants in Cambodia, raising cross-border concerns about transplant oversight. Global health awareness: World Hepatitis Day is marked on July 28, with renewed focus on breaking down viral hepatitis and expanding prevention and testing. Disaster response: Search and rescue efforts continued after a Vietnamese cargo ship sank in the South China Sea, with survivors receiving medical care and missing people still being sought.

Digital-Health Push: At the World Internet Conference’s Digital and Intelligent Health Forum, China’s health data and AI leaders argued for “AI-native hospitals,” with systems that rebuild workflows around semantic interaction, plus NHSA plans to aggregate insurance and drug traceability data for 1.33 billion insured people. Rehab Tech for Disability: China’s Disabled Persons’ Federation says it will scale need-driven brain-computer interface applications for smart rehabilitation during 2026-2030, aiming to match R&D to real disability needs. Sleep as a Target: A forum talk highlighted digital sleep monitoring and an “AI sleep agent,” citing 300 million people in China affected by sleep disorders and pushing proactive, device-supported care. Smart Ports: China unveiled a five-year plan to modernize customs and inspections using AI, smart scanning and inspection robots, targeting faster clearance and wider intelligent equipment coverage by 2030. Cancer Drug Update: AstraZeneca reported phase 3 CLARITY-Gastric01 results showing Sonesitatug vedotin improved overall survival in CLDN18.2+ advanced gastric/GEJ/esophageal cancers, with full data expected for regulators and upcoming meetings. Heat-Work Safety: Nanjing sanitation workers received air-conditioning vests with low-noise fans, part of broader urban governance efforts to protect outdoor workers in summer. Global Health Tech Angle: APEC economies reaffirmed responsible AI development, including practical governance and inclusive adoption, with healthcare access cited as a key use case.

Digital Health & Diagnostics: OnsiteGene unveiled myNAT, a palm-sized, battery-powered real-time PCR device aimed at bringing molecular testing into clinics and field settings with a full 40-cycle run in under 10 minutes. Cancer Care: Fosun Health in Guangzhou completed cell collection for its first patient using Kailimei® (solid-tumor CAR-T), marking the start of standardized clinical use in the Greater Bay Area. Public Health Tech: China’s sports authority highlighted a digital fitness push—using tech for better access to guidance, unified smart platforms, and personalized exercise risk management. Genetics & Respiratory Disease Research: New studies map asthma susceptibility and COPD self-management needs for digital tools, while other work explores pediatric inflammatory disorder frameworks and congenital heart gene regulation. Maternal Health Testing: Shuwen Biotech announced SyphiDuo™, a dual POCT for treponemal and non-treponemal syphilis antibodies to support screening and prevention of congenital syphilis. Health & Safety Alerts: Flash floods in Gansu killed at least 10 and injured 23 at a tourist campsite, with rescue teams saving 174 people. Food & Wellness Market: Oatly reported revenue growth and said it’s pivoting to become a “full-on” beverages company, with volume growth in Greater China amid tougher competition.

Gene-Editing Safety: Reports say a 6-year-old girl died days after an experimental brain-targeted gene-editing therapy, reigniting questions about trial oversight and transparency in China’s fast-moving biotech. Antibiotic Resistance: A new study suggests pets may play a bigger role than farm animals in spreading carbapenem-resistant Acinetobacter baumannii to humans, pointing to close human-pet contact as a key risk. Food Safety: Dried lily bulbs sold in Macau were found to contain excessive cadmium, prompting calls to stop selling/consuming the product and reminding people to avoid unbalanced intake. Disaster & Health Access: Typhoon Noul killed at least 10 in China and triggered mass evacuations and major travel disruption, with flash flooding in Gansu adding to the public health strain. Platform Economy Regulation: China fined Trip.com heavily for antitrust abuses tied to unfair hotel terms and tech-influenced pricing, a reminder that “health” for consumers also includes fair market rules. Agriculture & Nutrition: China announced a hybrid rice system with 99% self-cloning efficiency, aiming to cut annual seed costs while preserving yields.

AI & Health Tech: Peking University researchers published in Nature a new AlphaFold3-based gene-editing design framework (ContactSeek) aimed at improving base-editing precision and reducing off-target edits—an important step for safer gene therapies. Brain Health: A large French analysis links working longer to lower dementia risk, with the strongest signal tied to complex social work that builds cognitive reserve. Gene-therapy Safety Watch: Separate reporting highlights ongoing scrutiny after fatal gene-editing trials in China, keeping regulators and ethics front and center. Public Health & Food Safety: Taiwan saw a major Taipei rally over a soybean salad oil scandal, with protesters accusing authorities of slow response and poor transparency. Disaster Response: Typhoon Noul hit Guangdong and parts of Fujian with heavy rain, injuries, and large-scale evacuations, while hospitals treated storm-related cases. Policy & Access: China’s antitrust penalty on Trip.com underscores tighter oversight of platform practices that can affect consumer costs and service fairness. Robotics for Care: A Beijing humanoid robotics center showcased robots being developed for real-world healthcare and logistics tasks, signaling growing tech support for health services.

Antitrust & Platform Economy: China’s market regulator fined Trip.com Group $765M (5.18B yuan total) for monopoly abuses in online travel, ordering refunds to hotels and requiring public rectification after an investigation into exclusive dealing and pressure on hotels to avoid rivals. AI Policy Clash: A public split in Silicon Valley is intensifying over open-source AI, as US regulators face pressure to restrict open models amid claims that Chinese systems gained an edge through improper data practices. Brain Health Research: A large study links dementia, alcohol addiction, and several psychiatric disorders to increased “brain ageing” patterns on MRI, while ADHD and autism showed no such shift. Clinical Trials Watch: India’s regulators gave the go-ahead for a Phase III trial of Zydus’ Desidustat oral tablets for sickle cell anemia after Phase II results, targeting patients with limited options. Public Health Warning: Doctors are urging people to avoid a viral China social-media weight-loss trend mixing external-use constipation medication with sugar-free tea, after hospital cases of severe side effects. Energy Transition: China’s wind and solar capacity surpassed thermal power for the first time during the 14th Five-Year Plan period, signaling continued momentum in low-carbon supply. Health & Wellness Tourism: Foreign diplomatic envoys visited Hainan, including Boao Lecheng’s medical tourism zone, highlighting interest in China’s healthcare and wellness institutions.

Antitrust Crackdown: China’s market regulator hit Trip.com with a record 5.18 billion yuan penalty for abusing dominance in online hotel booking, including forcing exclusive deals and pushing hotels to offer the lowest rates. Public Health & Safety: Doctors in China warned against a viral weight-loss trend mixing external-use constipation medicine with tea after reports of severe diarrhea and vomiting sent people to emergency care. Sleep Research: Chinese scientists reported a small molecule, tryptamine, may help regulate sleep pressure, with animal results pointing to the GPR139 receptor as a potential insomnia target. Healthcare Access & Tech: A trial suggests fecal microbiota transplants can improve chronic insomnia sleep duration and reduce night waking for up to six months. Medical Ethics & Oversight: A gene-editing trial in China is under scrutiny after a fatal case raised questions about gene therapy rules and monitoring. Health Policy: China’s regulator also moved to tighten rules around sensitive biometric equipment procurement, after claims that Chinese-made face/fingerprint systems were used across government agencies. Education & AI: Universities in China are debating what to teach when AI becomes a co-teacher, with educators focusing on using AI to free class time for deeper questions. Disaster Response: A loess collapse in Shanxi buried a house, killing five and injuring three, with large-scale rescue and medical response underway.

Gene Therapy Safety: A joint investigation reports a 6-year-old girl in China died within a week after an experimental gene therapy for a rare disorder, reigniting scrutiny of gene-therapy oversight. FDA & Peptides: A US advisory panel narrowly backed easing restrictions on injectable peptides popular with wellness influencers, a move that could expand telehealth marketing despite safety concerns. Sweeteners & Gut Health: A new study links several commercially used sweeteners to slowed or halted growth of beneficial gut bacteria, with stronger effects when combined with certain compounds or drugs. AI Governance & Companions: China’s AI companion rules are tightening after concerns about addiction and social harm, while global debate grows over how to govern increasingly capable AI systems. Biopharma Manufacturing: US FDA completed a successful inspection of Asymchem’s carbapenem API site in China, marking a key regulatory milestone for advanced continuous-flow production. Pediatric Auto-Inflammation: Chinese researchers published a clinical framework mapping pediatric Behçet’s spectrum disorders to improve early recognition and genetic prioritization. Foreigners’ Services: SinoGuide launched a one-stop app for foreign nationals in China, bundling payments, transport, healthcare info, and policy reminders.

TCM Tourism Boom: A 376-year-old Hangzhou clinic is seeing a steady rise in foreign visitors trying moxibustion and cupping, as “ChinaTravel” bloggers spotlight traditional Chinese medicine for “sub-health” issues. South China Sea Flashpoints: The Philippines accuses China Coast Guard vessels of water-cannon attacks near Scarborough Shoal, escalating a week of confrontations after earlier baton-related injuries and medical evacuations. Gene-Editing Trial Scrutiny: A reported death of a six-year-old in a Shanghai gene-editing study is drawing fire over transparency and oversight as China expands biotech ambitions. Sepsis Brain Complications: A new review highlights how sepsis-associated encephalopathy may involve neuroinflammation, blood-brain barrier disruption, and metabolic reprogramming, linking it to worse outcomes. Mental Health Capacity in Hong Kong: Kwai Chung Hospital begins phased relocation of psychiatric inpatient services into new blocks, adding 1,000 beds for adult and child/adolescent care. Wellness Travel Spotlight: The Global Wellness Summit’s 20th anniversary in Thailand will focus on longevity medicine, women’s health, precision care, and “neuroarts” as wellness merges deeper with healthcare. Drug Tariff Shock (US): Trump’s plan for 100% tariffs on imported generic medicines from August 2028 raises alarms about higher prices and access risks.

Mosquito-borne disease control: Macau’s Health Bureau is stepping up mosquito control and inspections as dengue and chikungunya risks rise during summer travel, targeting breeding sites at high-risk locations and increasing operations at “hygiene black spots.” Education + health focus: China is pushing a new phase of basic education that puts “virtue” and a health-first approach at the center, alongside better resource allocation and tighter school-family-society coordination. Digital health research: Macau University of Science and Technology (MUST) is expanding its Respiratory Disease AI Laboratory with an international advisory team and a China-Portugal “trusted research environment” collaboration aimed at safer, multi-site public health computing. Mental health training: Hong Kong Mental Wellness Association launched an International Chapter of its Mental Wellness Ambassadors program, training community members to spot emotional distress and guide people to professional help. Antibiotic resistance in kids: A large global study reports rising drug-resistant infections among children across regions from 2004–2022, warning that last-line options could tighten further by 2035. Adult orthodontic care: International expert consensus guidance targets safer, evidence-based adult orthodontics, including strategies for alveolar ridge augmentation and complex periodontal or skeletal cases. Healthcare cybersecurity: Group-IB reports a China-nexus operation (JadeProx) using a Windows loader to target government and healthcare organizations across Asia and Latin America. Pharma supply chain demand: West Pharmaceutical Services raised its outlook as strong demand for injectable drug components—especially for diabetes and obesity treatments—keeps growing.

Public Health Policy: Nepal’s debate over raising sin taxes spotlights how higher prices for tobacco, alcohol, and sugar-sweetened drinks can cut non-communicable disease burdens while boosting revenue. Healthcare Innovation & Research: A study explores bee venom as an add-on to standard Parkinson’s therapy in mice, aiming to improve motor and cognitive outcomes. China’s Health System Push: China’s first-half fiscal spending shows health and wellness outpacing overall growth, with childcare subsidies a key driver. Digital Medicine in Practice: CityUHK and Shanghai’s National Facility for Translational Medicine launch a Greater Bay Area branch center to speed real-world digital medicine and healthcare innovation. Drug Development Acceleration: Reuters reports Insilico says AI plus China’s research ecosystem can shrink drug discovery timelines to about a year. Minor Ailment Self-Care: Kenvue plans to expand minor ailment management in China as public health literacy and universal coverage efforts grow. Food Safety & Risk: A report warns that poor restaurant hygiene can drive foodborne illness—an everyday health issue with big downstream costs. Global Health Trade: Zimbabwe ships its first blueberry batch to China under a new phytosanitary protocol, showing how health standards can unlock market access. Disaster Response: Yunnan activates Level-IV emergency response after a 5.0 earthquake, with no casualties reported so far.

Generic Drug Tariffs: US President Trump outlined a phased tariff plan for imported generics—zero through Aug 2026, then 100% in 2028 and 200% in 2029—aimed at pushing “reshoring” of generic manufacturing, raising concerns about shortages and higher costs for patients. China Pharma Supply Chain Exposure: Reporting notes China’s dominance in upstream active ingredients means the impact could reach beyond finished-product exporters, putting pressure on regional pharma supply networks. Regulatory & Market Moves: Novo Nordisk sued Eli Lilly over alleged misleading GLP-1 ads, while Haisco’s ciprofol (Cipepofol) cleared the US FDA with Jiuzhou Pharma CDMO support—another sign of China-made anesthesia innovation pushing into Western markets. Infectious Disease Watch (Macau): Macau reported 2,755 notifiable cases in June; influenza led, with big month-on-month jumps in enterovirus, norovirus, and scarlet fever. COVID Update (Taiwan): Taiwan entered a new COVID epidemic phase as weekly cases rose 66.5%, with health authorities urging hygiene, masks in healthcare, and vaccination. Heat Safety (Macau): A yellow heat alert prompted warnings on heatstroke and related illnesses, including heat exhaustion and cramps. Healthcare Access Policy: Bangladesh plans a “National Health Card” to reduce the urban-rural gap by enabling doctors to access records nationwide. Tech for Care: WAIC-linked news highlights AI and enterprise health applications, including new healthcare AI solutions and AI-driven initiatives.

Ayungin Medical Evacuation Dispute: Philippine officials say China Coast Guard didn’t “permit” the evacuation of two injured sailors, arguing the mission was handled under Manila’s authority within its EEZ, while AFP calls Beijing’s claim a “false narrative.” PLA Humanitarian Care Abroad: China’s navy hospital ship Auspicious Ark sailed from Qingdao for a 200+ day Mission Harmony-2026, offering free medical services across Africa and South Asia. Education Quality Push: China’s basic education reforms are shifting from expanding access to improving quality, with more rural students getting hands-on science and innovation training. BRICS Integrative Medicine Track: BRICS health officials met in Chandigarh to strengthen collaboration on traditional, complementary and integrative medicine, finalizing plans for an expert working group. Dengue Prevention in Macau: Wynn Macau began mosquito control after a dengue case linked to a recent visitor stay, with targeted vector control around the site. Elderly Care via AI: A report highlights how China’s AI-driven robotics and services are being positioned to support ageing populations, including in Kenya. Market Signals for Health Tech: WuXi AppTec was named again to the FTSE4Good sustainability index, underscoring ongoing investor focus on responsible pharma operations.